Abbott And Teva Settle Fight Over Biaxin

Law360, New York (August 2, 2006, 12:00 AM EDT) -- Teva Pharmaceuticals USA and Abbott Laboratories have settled a patent infringement lawsuit over the marketing of a generic version of Abbott’s extended-release antibiotic Biaxin.

In documents filed Monday, the two companies asked the court to dismiss the case.

Terms of the settlement were not disclosed in court documents. Whether the settlement changes plans Teva had to sell a generic version of Biaxin remains unclear.

Jonathon Hamilton, a spokesperson for Abbott, said the terms were confidential and that he couldn’t say whether the settlement affects Teva’s sale...
To view the full article, register now.